MNV-201 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV
Phase 2 · Mitochondrial Diseases, Pearson Syndrome |
Minovia Therapeutics Ltd. | MNV-201 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|